Trial Profile
Safety and Effectiveness of Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation: a Multi-database Cohort Study With Meta-analysis (DOACs vs DOACs)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Stroke; Thromboembolism
- Focus Therapeutic Use
- Acronyms DOACs vs DOACs
- 26 Nov 2020 Results published in the British Journal of Clinical Pharmacology
- 03 Jul 2018 New trial record